Cargando…
Clinical Utility of Pre-Therapeutic [18F]FDG PET/CT Imaging for Predicting Outcomes in Breast Cancer
Background: [18F]FDG PET/CT is used for staging and could also provide information associated with clinical outcomes. The objective of this study was to determine the clinical utility of biomarkers measured using [18F]FDG PET/CT to predict the absence of pathological complete response (no-pCR) and r...
Autores principales: | Najid, Sophia, Seban, Romain-David, Champion, Laurence, De Moura, Alexandre, Sebbag, Clara, Salaün, Hélène, Cabel, Luc, Bonneau, Claire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488013/ https://www.ncbi.nlm.nih.gov/pubmed/37685551 http://dx.doi.org/10.3390/jcm12175487 |
Ejemplares similares
-
Immune Response Visualized In Vivo by [18F]-FDG PET/CT after COVID-19 Vaccine
por: Seban, Romain-David, et al.
Publicado: (2021) -
Immune-Related Erythema Nodosum Mimicking in Transit Melanoma Metastasis on [18F]-FDG PET/CT
por: Seban, Romain-David, et al.
Publicado: (2021) -
Assessing immune response upon systemic RNA vaccination on [18F]-FDG PET/CT for COVID-19 vaccine and then for immuno-oncology?
por: Seban, Romain-David, et al.
Publicado: (2021) -
(18)F-FDG PET/CT in Relapsed Endometrial Cancer Treated with Preoperative PD-1 Inhibitor Dostarlimab
por: Seban, Romain-David, et al.
Publicado: (2021) -
Absolute Lymphocyte Count After COVID-19 Vaccination Is Associated with Vaccine-Induced Hypermetabolic Lymph Nodes on (18)F-FDG PET/CT: A Focus in Breast Cancer Care
por: Seban, Romain-David, et al.
Publicado: (2022)